USERS' GUIDES TO THE MEDICAL LITERATURE. II: HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION A. ARE THE RESULTS OF THE STUDY VALID ?

CLINICAL SCENARIO You are working as an internal medicine resident in a rheumatology rotation and are seeing a 19-year-old woman who has had systemic lupus erythematosus diagnosed on the basis of a characteristic skin rash, arthritis, and renal disease. A renal biopsy has shown diffuse proliferative nephritis. A year ago her creatinine level was 140 μmol/L, 6 months ago it was 180 μmol/L, and in a blood sample taken a week before this clinic visit, 220 μmol/L. Over the last year she has been taking prednisone, and over the last 6 months, cyclophosphamide, both in appropriate doses. You are distressed by the rising creatinine level and the rheumatology fellow with whom you discuss the problem suggests that you contact the hematology service to consider a trial of plasmapheresis. The fellow states that plasmapheresis is effective in reducing the level of the antibodies responsible for the nephritis and cites a number

[1]  G H Guyatt,et al.  Effect of encouragement on walking test performance. , 1984, Thorax.

[2]  G. Hogarty,et al.  Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. , 1974, Archives of general psychiatry.

[3]  Marie E. Latulippe,et al.  A controlled trial of corticosteroid injections into facet joints for chronic low back pain. , 1991, The New England journal of medicine.

[4]  W. Asher,et al.  Effect of human chorionic gonadotrophin on weight loss, hunger, and feeling of well-being"2 , 1973 .

[5]  T. Clemmer,et al.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.

[6]  R. Fuller,et al.  Compliance with disulfiram treatment of alcoholism. , 1983, Journal of chronic diseases.

[7]  C. Viscoli,et al.  Treatment adherence and risk of death after a myocardial infarction , 1990, The Lancet.

[8]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: I. How to Get Started , 1993 .

[9]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[10]  F. Mosteller,et al.  How study design affects outcomes in comparisons of therapy. I: Medical. , 1989, Statistics in medicine.

[11]  J D Emerson,et al.  An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. , 1990, Controlled clinical trials.

[12]  M. Dalakas,et al.  Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. , 1992, The New England journal of medicine.

[13]  E. Lewis,et al.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. , 1992, The New England journal of medicine.

[14]  D. Sackett,et al.  Functional status changes following medical or surgical treatment for cerebral ischemia. Results of the extracranial-intracranial bypass study. , 1987, JAMA.

[15]  T C Chalmers,et al.  Bias in treatment assignment in controlled clinical trials. , 1983, The New England journal of medicine.

[16]  T. Berl,et al.  Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. , 1991, Annals of internal medicine.

[17]  E. Lewis,et al.  Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study , 1992, Annals of Internal Medicine.

[18]  B. Kramer,et al.  Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. , 1983, The Journal of pediatrics.